Abstract
Objectives Extreme but discrete fine particle <2.5μm (PM2.5) exposure is associated with higher prevalence of respiratory symptoms. It was unknown whether these effects abate, persist, or worsen over time, nor whether they are exacerbated by COVID-19.
Methods We analysed longitudinal survey data from a cohort residing near a 2014 coalmine fire in regional Australia. A 2016/2017 survey included 4,056 participants, of whom 612 were followed-up in 2022. Items included questions on respiratory symptoms, history of COVID-19, and time-location diaries that were combined with geospatial and temporal models of fire-related PM2.5. Associations were examined using logistic and mixed-effects logistic regressions.
Results PM2.5 exposure predicted higher prevalence of chronic cough and current wheeze 2-3 years post-fire. At the 2022 follow-up, PM2.5 exposure was associated with worsening prevalence of chronic cough and possibly current wheeze. While there were no detectable interaction effects between PM2.5 and COVID-19, PM2.5 exposure was associated with additional respiratory symptoms among participants who reported a history of COVID-19.
Conclusion Short-term but extreme PM2.5 may increase the long-term prevalence of chronic cough, while COVID-19 may exacerbate the effect on additional respiratory symptoms.
Competing Interest Statement
MJA holds investigator-initiated grants from Pfizer, Boehringer-Ingelheim, Sanofi and GlaxoSmithKline for unrelated research. He has undertaken an unrelated consultancy for Sanofi and received a speaker's fee from GSK. The other authors declare no other competing interests.
Clinical Protocols
Funding Statement
This study was funded by the Department of Health, State Government of Victoria, though it represents the views of the authors and not the Department.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The Monash University Human Research Ethics Committee (MUHREC) of Monash University gave ethical approval for this work as part of the Hazelwood Adult Survey & Health Record Linkage Study (Project ID: 25680; previously CF15/872 - 2015000389 and 6066)
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Research funding This study was funded by the Department of Health, State Government of Victoria, but represents the views of the authors and not the Department.
Competing interests MJA holds investigator-initiated grants from Pfizer, Boehringer-Ingelheim, Sanofi and GlaxoSmithKline for unrelated research. He has undertaken an unrelated consultancy for Sanofi and received a speaker’s fee from GSK. The other authors declare no other competing interests.
This manuscript has been revised to add new outcomes, chronic wet cough and chronic dry cough, which were derived from the chronic cough and chronic phlegm outcomes.
Data Availability
All data produced in the present study are confidential survey responses and therefore cannot be shared. However, we have provided a link to a public repository on which we have archived our cleaning and analytical code.
